NCT03558867View on ClinicalTrials.gov

Personalised Medicine in Pre-diabetes and Early Type 2 Diabetes

NACompletedINTERVENTIONAL
Enrollment

138

Participants

Timeline

Start Date

June 5, 2018

Primary Completion Date

December 15, 2023

Study Completion Date

July 23, 2024

Conditions
Pre DiabetesType 2 Diabetes Mellitus
Interventions
DRUG

Metformin + Healthy diet

Metformin (1500 mg/d, Extended Release) + Healthy, low fat diet

DRUG

Metformin + Personalized diet

Metformin (1500 mg/d, Extended Release) + Algorithm-based personalized diet

Trial Locations (1)

2010

Garvan Institute of Medical Research, Sydney

Sponsors
All Listed Sponsors
collaborator

Weizmann Institute of Science

OTHER

lead

Garvan Institute of Medical Research

OTHER